NG
Nancy A. Grygiel
SVP & CCO

Nancy A. Grygiel insider trades: Amgen (AMGN) stock sales

SVP & CCO, Amgen Last trade Aug 6, 2026 44 Form 4 filings
$2.7M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Nancy reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 6, 2026AMGN↓ Sell$1.2M
May 4, 2026AMGN↓ Sell$400K
Nov 20, 2025AMGN↓ Sell$1.1M
Aug 20, 2025AMGN↓ Sell$376K
Feb 5, 2025AMGN↓ Sell$484K
May 3, 2024AMGN↓ Sell$663K
Dec 4, 2023AMGN↓ Sell$572K
Nov 8, 2022AMGN↓ Sell$160K
May 11, 2021AMGN↓ Sell$631K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AMGN insiders

Open-market trades in the last 12 months

About Nancy A. Grygiel's insider trades

Nancy A. Grygiel is SVP & CCO at Amgen (AMGN). Since May 11, 2021, Nancy has reported no open-market purchases and 9 sales worth $5.5M on SEC Form 4. In the last 12 months: 3 sales ($2.7M).

Their filings also include shares withheld for taxes (28 filings), grants and awards (14 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.